These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging. Jobst KA; Barnetson LP; Shepstone BJ Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442 [TBL] [Abstract][Full Text] [Related]
3. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e. Susanto TA; Pua EP; Zhou J; J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955 [TBL] [Abstract][Full Text] [Related]
4. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort. Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016 [TBL] [Abstract][Full Text] [Related]
6. Associations of Regional Brain Structural Differences With Aging, Modifiable Risk Factors for Dementia, and Cognitive Performance. Suzuki H; Venkataraman AV; Bai W; Guitton F; Guo Y; Dehghan A; Matthews PM; JAMA Netw Open; 2019 Dec; 2(12):e1917257. PubMed ID: 31825506 [TBL] [Abstract][Full Text] [Related]
7. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype. Payami H; Grimslid H; Oken B; Camicioli R; Sexton G; Dame A; Howieson D; Kaye J Am J Hum Genet; 1997 Apr; 60(4):948-56. PubMed ID: 9106542 [TBL] [Abstract][Full Text] [Related]
8. Hypertension and dementia. Nagai M; Hoshide S; Kario K Am J Hypertens; 2010 Feb; 23(2):116-24. PubMed ID: 19927134 [TBL] [Abstract][Full Text] [Related]
9. Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Kalaria RN Nutr Rev; 2010 Dec; 68 Suppl 2(Suppl 2):S74-87. PubMed ID: 21091952 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population. Brayne C; Harrington CR; Wischik CM; Huppert FA; Chi LY; Xuereb JH; O'Connor DW; Paykel ES Dementia; 1996; 7(3):169-74. PubMed ID: 8740632 [TBL] [Abstract][Full Text] [Related]
11. The Effect of Traumatic Brain Injury History with Loss of Consciousness on Rate of Cognitive Decline Among Older Adults with Normal Cognition and Alzheimer's Disease Dementia. Tripodis Y; Alosco ML; Zirogiannis N; Gavett BE; Chaisson C; Martin B; McClean MD; Mez J; Kowall N; Stern RA J Alzheimers Dis; 2017; 59(1):251-263. PubMed ID: 28655133 [TBL] [Abstract][Full Text] [Related]
12. The complex interplay of cardiovascular system and cognition: how to predict dementia in the elderly? Kerola T; Kettunen R; Nieminen T Int J Cardiol; 2011 Jul; 150(2):123-9. PubMed ID: 21094551 [TBL] [Abstract][Full Text] [Related]
13. Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Rockwood K; Ebly E; Hachinski V; Hogan D Arch Neurol; 1997 Jan; 54(1):33-9. PubMed ID: 9006411 [TBL] [Abstract][Full Text] [Related]
14. White matter hyperintensities and imaging patterns of brain ageing in the general population. Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801 [TBL] [Abstract][Full Text] [Related]
17. Evidence of neurodegeneration in obstructive sleep apnea: Relationship between obstructive sleep apnea and cognitive dysfunction in the elderly. Daulatzai MA J Neurosci Res; 2015 Dec; 93(12):1778-94. PubMed ID: 26301370 [TBL] [Abstract][Full Text] [Related]
18. History of Dementia. Assal F Front Neurol Neurosci; 2019; 44():118-126. PubMed ID: 31220848 [TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction. Henry-Feugeas MC Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]